GlyCosmos PubAnnotations

Recent publication annotations of glycans, cell types, and proteins, from PubAnnotation.

Displaying entries 9651 - 9675 of 24862 in total
Title ▲ Authors PubMed ID Source Publication Year
Heparin-like molecules on the cell surface potentiate binding of diphtheria toxin to the diphtheria toxin receptor/membrane-anchored heparin-binding epidermal growth factor-like growth factor.
  • Shishido Y
  • Sharma KD
  • Higashiyama S
  • Klagsbrun M
  • Mekada E
7494001 J Biol Chem 1995
Heparin-modulated binding of pancreatic lipase and uptake of hydrolyzed triglycerides in the intestine.
  • Bosner MS
  • Gulick T
  • Riley DJ
  • Spilburg CA
  • Lange LG
2584217 J Biol Chem 1989
Heparin-releasable and nonreleasable lipoprotein lipase in the perfused rat heart.
  • Ben-Zeev O
  • Schwalb H
  • Schotz MC
7287722 J Biol Chem 1981
Heparin/Heparan sulfate domains in binding and signaling of fibroblast growth factor 8b.
  • Loo BM
  • Salmivirta M
12077148 J Biol Chem 2002
Heparin/heparan sulfate (HP/HS) interacting protein (HIP) supports cell attachment and selective, high affinity binding of HP/HS.
  • Liu S
  • Hoke D
  • Julian J
  • Carson DD
9325317 J Biol Chem 1997
Heparin/heparan sulfate 6-O-sulfatase from Flavobacterium heparinum: integrated structural and biochemical investigation of enzyme active site and substrate specificity.
  • Myette JR
  • Soundararajan V
  • Shriver Z
  • Raman R
  • Sasisekharan R
19726671 J Biol Chem 2009
Heparin/heparan sulfate N-sulfamidase from Flavobacterium heparinum: structural and biochemical investigation of catalytic nitrogen-sulfur bond cleavage.
  • Myette JR
  • Soundararajan V
  • Behr J
  • Shriver Z
  • Raman R
  • Sasisekharan R
19726673 J Biol Chem 2009
Heparin/heparan sulfate biosynthesis: processive formation of N-sulfated domains.
  • Carlsson P
  • Presto J
  • Spillmann D
  • Lindahl U
  • Kjellén L
18487608 J Biol Chem 2008
Heparinase 1 selectivity for the 3,6-di-O-sulfo-2-deoxy-2-sulfamido-alpha-D-glucopyranose (1,4) 2-O-sulfo-alpha-L-idopyranosyluronic acid (GlcNS3S6S-IdoA2S) linkages.
  • Xiao Z
  • Zhao W
  • Yang B
  • Zhang Z
  • Guan H
  • Linhardt RJ
20729345 Glycobiology 2011
Heparinase I from Flavobacterium heparinum. Mapping and characterization of the heparin binding domain.
  • Sasisekharan R
  • Venkataraman G
  • Godavarti R
  • Ernst S
  • Cooney CL
  • Langer R
8621711 J Biol Chem 1996
Heparinase I from Flavobacterium heparinum. Role of positive charge in enzymatic activity.
  • Godavarti R
  • Sasisekharan R
9417072 J Biol Chem 1998
Heparinase II from Flavobacterium heparinum. Role of cysteine in enzymatic activity as probed by chemical modification and site- directed mutagenesis.
  • Shriver Z
  • Hu Y
  • Pojasek K
  • Sasisekharan R
9722510 J Biol Chem 1998
Heparinase II from Flavobacterium heparinum. Role of histidine residues in enzymatic activity as probed by chemical modification and site-directed mutagenesis.
  • Shriver Z
  • Hu Y
  • Sasisekharan R
9553064 J Biol Chem 1998
Heparosan-coated liposomes for drug delivery.
  • Lane RS
  • Haller FM
  • Chavaroche AAE
  • Almond A
  • DeAngelis PL
29044377 Glycobiology 2017
Heparosan-glucuronate 5-epimerase: Molecular cloning and characterization of a novel enzyme.
  • Mochizuki H
  • Yamagishi K
  • Suzuki K
  • Kim YS
  • Kimata K
25677302 Glycobiology 2015
Hepatic Ah receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin. Partial stabilization by molybdate.
  • Denison MS
  • Vella LM
  • Okey AB
3015922 J Biol Chem 1986
Hepatic Aryl Hydrocarbon Receptor Attenuates Fibroblast Growth Factor 21 Expression.
  • Girer NG
  • Murray IA
  • Omiecinski CJ
  • Perdew GH
27226639 J Biol Chem 2016
Hepatic Bax inhibitor-1 inhibits IRE1alpha and protects from obesity-associated insulin resistance and glucose intolerance.
  • Bailly-Maitre B
  • Belgardt BF
  • Jordan SD
  • Coornaert B
  • von Freyend MJ
  • Kleinridders A
  • Mauer J
  • Cuddy M
  • Kress CL
  • Willmes D
  • Essig M
  • Hampel B
  • Protzer U
  • Reed JC
  • Brüning JC
19996103 J Biol Chem 2010
Hepatic FoxO1 ablation exacerbates lipid abnormalities during hyperglycemia.
  • Haeusler RA
  • Han S
  • Accili D
20573950 J Biol Chem 2010
Hepatic HAX-1 inactivation prevents metabolic diseases by enhancing mitochondrial activity and bile salt export.
  • Alogaili F
  • Chinnarasu S
  • Jaeschke A
  • Kranias EG
  • Hui DY
32079675 J Biol Chem 2020
Hepatic Ins(1,3,4,5)P4 3-phosphatase is compartmentalized inside endoplasmic reticulum.
  • Ali N
  • Craxton A
  • Shears SB
8384201 J Biol Chem 1993
Hepatic Insulin Resistance Following Chronic Activation of the CREB Coactivator CRTC2.
  • Hogan MF
  • Ravnskjaer K
  • Matsumura S
  • Huising MO
  • Hull RL
  • Kahn SE
  • Montminy M
26342077 J Biol Chem 2015
Hepatic PCSK9 expression is regulated by nutritional status via insulin and sterol regulatory element-binding protein 1c.
  • Costet P
  • Cariou B
  • Lambert G
  • Lalanne F
  • Lardeux B
  • Jarnoux AL
  • Grefhorst A
  • Staels B
  • Krempf M
16407292 J Biol Chem 2006
Hepatic ZIP14-mediated Zinc Transport Contributes to Endosomal Insulin Receptor Trafficking and Glucose Metabolism.
  • Aydemir TB
  • Troche C
  • Kim MH
  • Cousins RJ
27703010 J Biol Chem 2016
Hepatic de novo synthesis of glucose 6-phosphate is not affected in peroxisome proliferator-activated receptor alpha-deficient mice but is preferentially directed toward hepatic glycogen stores after a short term fast.
  • Bandsma RH
  • Van Dijk TH
  • Harmsel At At
  • Kok T
  • Reijngoud DJ
  • Staels B
  • Kuipers F
14688286 J Biol Chem 2004

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024